Armodafinil is a prescription stimulant-like medication that promotes alertness and combats excessive daytime sleepiness (EDS). It’s the R-enantiomer of modafinil, offering a longer half-life for sustained wakefulness. Clinically approved for narcolepsy, residual sleepiness from obstructive sleep apnea (OSA), and shift work sleep disorder (SWSD), it helps patients stay focused and productive during waking hours.
-
Persistent drowsiness or “heavy eyelids” despite adequate nighttime sleep
-
Difficulty concentrating, memory lapses
-
Sudden “sleep attacks” or micro-sleeps during day
-
Impaired performance at work or school
-
Mood changes: irritability or low motivation
-
-
Narcolepsy: Neurological disorder causing uncontrollable sleep episodes
-
Obstructive Sleep Apnea (OSA): Airway collapse leads to fragmented sleep
-
Shift Work Sleep Disorder: Rotating or night shifts conflicting with natural circadian rhythms
-
Insufficient Sleep: Chronic sleep deprivation from lifestyle or insomnia
-
Medication Side Effects: Sedating drugs, antidepressants, or antihistamines
-
-
Irregular Sleep Schedule: Frequent bedtime changes
-
Sleep Environment: Light, noise, or uncomfortable bedding
-
Shift Rotations: Early morning or overnight shifts
-
Alcohol & Sedatives: Late-night alcohol or sleeping pills that fragment sleep
-
Underlying Health Issues: Thyroid dysfunction, depression, or chronic pain
-
-
Clinical History: Daytime sleepiness scales (e.g., Epworth Sleepiness Scale)
-
Polysomnography (Sleep Study): Measures breathing, oxygen, and sleep stages overnight
-
Multiple Sleep Latency Test (MSLT): Assesses speed of falling asleep during daytime naps
-
Actigraphy: Wrist-worn tracker of sleep–wake patterns over several days
-
Consultation: Review of medications, lifestyle, and comorbid conditions
-
-
Armodafinil (150 mg, 250 mg): Once-daily morning dose for narcolepsy and OSA residual sleepiness
-
Modafinil: Alternative wakefulness agent
-
Behavioral Measures: Sleep hygiene, scheduled naps, consistent sleep–wake routine
-
CPAP Therapy: First-line for OSA to reduce apneas and improve sleep quality
-
Light Therapy: Timed bright-light exposure for shift-work disorder
-
Q1: How soon does armodafinil start working?
A: Most patients feel increased alertness within 30–60 minutes; peak effect at 2–4 hours.
Q2: Can I take armodafinil twice daily?
A: It’s designed for once-daily dosing. Splitting doses can disrupt nighttime sleep.
Q3: What are common side effects?
A: Headache, nausea, dry mouth, and insomnia—usually mild and transient.
Q4: Is armodafinil addictive?
A: It has low abuse potential compared to traditional stimulants, but use under medical supervision is essential.
Q5: When should I take it?
A: For narcolepsy/OSA, take upon waking; for shift-work disorder, take 30–60 minutes before the work shift.